Intracarotid abciximab injection to abort impending ischemic stroke during carotid angioplasty

Cerebrovascular Diseases

Volumn 11, Issue 4, 2001, Pages 300-304

  Ho, David Sai Wah ^a,b   Wang, Yan ^a   Chui, Michele ^a   Wang, Yiqing ^a   Ho, Shu Leong ^a   Cheung, Raymond Tak Fai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Angioplasty; Antiplatelet; Carotid artery disease; Ischemic cerebrovascular event; Thrombolytic

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; AGED; ARTICLE; CAROTID ARTERY THROMBOSIS; CASE REPORT; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MALE; MIDDLE CEREBRAL ARTERY; NEUROLOGICAL COMPLICATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENT; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; ANTIBODIES, MONOCLONAL; BRAIN ISCHEMIA; CAROTID ARTERY, COMMON; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INJECTIONS, INTRA-ARTERIAL; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE CEREBRAL ARTERY; PLATELET AGGREGATION INHIBITORS; STENTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034989263     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047657     Document Type: Article

References (24)

1. Tissue plasminogen activator for acute ischemic stroke
2. Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys
3. Elective stenting of the extracranial carotid arteries
4. Carotid endarterectomy revisited
5. Current global status of carotid artery stent placement
6. Update of the immediate angiographic results and in hospital central nervous system complications of cerebral percutaneous transluminal angioplasty
7. Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: Preventive strategies
8. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemisphere stroke
9. Antiplatelet therapy in acute cerebral ischemia
10. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
11. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
12. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
13. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty
14. Effects of competitive platelet glycoprotein IIb/IIIa inhibition with Integrilin in reducing complications of percutaneous coronary intervention
15. Stroke after thrombolysis: Mortality and functional outcomes in the GUSTO-I trial
16. An international, randomized comparison of reteplase with alteplase for actue myocardial infarction
17. Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE)
18. The glycoprotein IIb/IIIa platelet receptor blocker tirofiban, but not heparin, counteracts platelet aggregation in unstable angina perctoris
19. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
20. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators
21. Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
22. IIb/IIIa blockade and thrombolytics: Early lessons from the SPEED and GUSTO IV trials
23. Basilar artery rethrombosis: Successful treatment with platelet glycoprotein IIb/IIIa receptor inhibitor
24. Abciximab in acute ischemic stroke: A randomized, double-blind, placebo-controlled, dose-escalation study